| Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology N Mullins, AJ Forstner, KS O’Connell, B Coombes, JRI Coleman, Z Qiao, ... Nature genetics 53 (6), 817-829, 2021 | 761 | 2021 |
| Dissecting the shared genetic architecture of suicide attempt, psychiatric disorders, and known risk factors N Mullins, JE Kang, AI Campos, JRI Coleman, AC Edwards, H Galfalvy, ... Biological psychiatry 91 (3), 313-327, 2022 | 137 | 2022 |
| Rethinking drug repositioning and development with artificial intelligence, machine learning, and omics M Koromina, MT Pandi, GP Patrinos Omics: a journal of integrative biology 23 (11), 539-548, 2019 | 99 | 2019 |
| Economic evaluation in psychiatric pharmacogenomics: a systematic review K Karamperis, M Koromina, P Papantoniou, M Skokou, F Kanellakis, ... The pharmacogenomics journal 21 (4), 533-541, 2021 | 40 | 2021 |
| Genome-wide association study of over 40,000 bipolar disorder cases provides novel biological insights L Jones, K Gordon-Smith, A Perry Nature Genetics, 2021 | 38 | 2021 |
| Prevalence of pharmacogenomic variants in 100 pharmacogenes among Southeast Asian populations under the collaboration of the Southeast Asian Pharmacogenomics Research Network … C Runcharoen, K Fukunaga, I Sensorn, N Iemwimangsa, S Klumsathian, ... Human genome variation 8 (1), 7, 2021 | 22 | 2021 |
| A novel machine learning-based approach for the computational functional assessment of pharmacogenomic variants MT Pandi, M Koromina, I Tsafaridis, S Patsilinakos, E Christoforou, ... Human Genomics 15, 1-13, 2021 | 19 | 2021 |
| The ethnogeographic variability of genetic factors underlying G6PD deficiency M Koromina, MT Pandi, PJ van der Spek, GP Patrinos, VM Lauschke Pharmacological Research 173, 105904, 2021 | 17 | 2021 |
| Genome-based therapeutic interventions for β-type hemoglobinopathies K Karamperis, MT Tsoumpeli, F Kounelis, M Koromina, C Mitropoulou, ... Human Genomics 15 (1), 32, 2021 | 15 | 2021 |
| What do students in pharmacy and medicine think about pharmacogenomics and personalized medicine education? Awareness, attitudes, and perceptions in Malaysian Health Sciences S Siamoglou, M Koromina, FM Moy, C Mitropoulou, GP Patrinos, ... Omics: a journal of integrative biology 25 (1), 52-59, 2021 | 14 | 2021 |
| Damaging coding variants within kainate receptor channel genes are enriched in individuals with schizophrenia, autism and intellectual disabilities M Koromina, M Flitton, A Blockley, IR Mellor, HM Knight Scientific reports 9 (1), 19215, 2019 | 14 | 2019 |
| Identification and functional validation of novel pharmacogenomic variants using a next-generation sequencing-based approach for clinical pharmacogenomics S Siamoglou, M Koromina, E Hishinuma, S Yamazaki, EE Tsermpini, ... Pharmacological Research 176, 106087, 2022 | 12 | 2022 |
| Attitudes and awareness toward pharmacogenomics and personalized medicine adoption among health sciences trainees: experience from Greece and lessons for Europe S Siamoglou, M Koromina, K Politopoulou, CG Samiou, G Papadopoulou, ... OMICS: A Journal of Integrative Biology 25 (3), 190-199, 2021 | 9 | 2021 |
| Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics M Koromina, S Koutsilieri, GP Patrinos Human Genomics 14, 1-10, 2020 | 9 | 2020 |
| Documentation of clinically relevant genomic biomarker allele frequencies in the next‐generation FINDbase worldwide database F Kounelis, A Kanterakis, A Kanavos, MT Pandi, Z Kordou, O Manusama, ... Human Mutation 41 (6), 1112-1122, 2020 | 8 | 2020 |
| Discovery of new drug indications for COVID-19: A drug repurposing approach P Kumari, B Pradhan, M Koromina, GP Patrinos, KV Steen Plos one 17 (5), e0267095, 2022 | 7 | 2022 |
| Nutrigenetics and nutrigenomics: ready for clinical use or still a way to go? M Koromina, V Konstantinidou, M Georgaka, F Innocenti, GP Patrinos Personalized Medicine 17 (3), 171-173, 2020 | 7 | 2020 |
| A kainate receptor GluK4 deletion, protective against bipolar disorder, is associated with enhanced cognitive performance across diagnoses in the TwinsUK cohort M Koromina, M Flitton, IR Mellor, HM Knight The World Journal of Biological Psychiatry, 2018 | 6 | 2018 |
| Discrepancies and similarities in the genome-informed guidance for psychiatric disorders amongst different regulatory bodies and research consortia using next generation … Z Kordou, M Skokou, EE Tsermpini, W Chantratita, K Fukunaga, ... Pharmacological Research 167, 105538, 2021 | 5 | 2021 |
| Exome-wide analysis of the DiscovEHR cohort reveals novel candidate pharmacogenomic variants for clinical pharmacogenomics MT Pandi, MS Williams, P van der Spek, M Koromina, GP Patrinos Genes 11 (5), 561, 2020 | 5 | 2020 |
